Rianlon Corporation (300596.SZ) Bundle
From its founding in 2003 to becoming the first A-share listed company in China's anti-aging industry on the Shenzhen ChiNext Board in 2017, Rianlon Corporation (ticker 300596.SZ) has built a global footprint-launching RIANOX® and RIASORB® in 2005, opening a European subsidiary in 2008, completing the Ningxia Zhongwei Base in 2011 and acquiring Korean IPI in 2024 to enter high-end electronic chemicals-while operating six major production bases (Tianjin, Ningxia, Zhejiang, Hebei, Guangdong and Inner Mongolia) and offering antioxidants, light stabilizers, U-pack customized blends and a broad suite of additives for industries from automotive and electronics to packaging and personal care; publicly held with about 229.62 million shares outstanding as of March 31, 2025, Rianlon's stated mission-"Chemistry and Biology, Creating a Bright Life"-underpins a technology- and innovation-driven model that generated 5.69 billion yuan in revenue in 2024 (up 7.74% year-on-year) and 504.54 million yuan in net income (up 17.61%), positioning the company as a leading global biochemical platform for polymer anti-aging solutions and customized formulation services
Rianlon Corporation (300596.SZ): Intro
Rianlon Corporation (300596.SZ) is a Chinese specialty chemical manufacturer focused on polymer anti-aging additives and, since 2024, high-end electronic chemicals following its acquisition of Korean IPI. The company combines proprietary antioxidant and light-stabilizer technologies with integrated production capacity and a global sales network to serve plastics, rubber, coatings, adhesives and emerging electronic-materials markets.- Founded: 2003 - entry into polymer anti-aging additives.
- Brand rollout: 2005 - global promotion and sales of RIANOX® (antioxidants) and RIASORB® (UV absorbers/UV stabilizers).
- European expansion: 2008 - establishment of a European subsidiary to strengthen presence in EU markets.
- Ningxia Zhongwei Base: 2011 - major capacity and production expansion in Ningxia, China.
- Public listing: 2017 - listed on Shenzhen ChiNext Board; first A-share listed company in China's anti-aging industry.
- Strategic acquisition: 2024 - acquisition of Korean IPI, entry into high-end electronic chemicals and expansion of product portfolio.
- Core products: Anti-oxidants (RIANOX®), UV absorbers and light stabilizers (RIASORB®), specialty intermediates and, post-2024, electronic-chemical grades from IPI.
- Revenue streams: product sales (domestic + exports), toll manufacturing, technical services and licensing for proprietary formulations.
- Go-to-market: direct sales teams in China, European subsidiary for regional commercial operations, distributor network across Asia, Americas and Africa, and OEM partnerships for tailored grades.
- Value drivers: proprietary IP, scale manufacturing (Ningxia base), global sales footprint, regulatory compliance for food-contact/medical/plastics applications, and diversification into electronics materials after IPI acquisition.
- Production hubs: Ningxia Zhongwei Base (established 2011) plus multiple domestic plants; European subsidiary supports logistics, customer service and local quality certification.
- International reach: products marketed in 60+ countries and regions via direct offices and distributors.
- Manufacturing capacity (approximate aggregate): 20,000-30,000 tonnes/year for polymer additives at full utilization following Ningxia expansion and upgrades.
- 2003 - Company founded; R&D focus on polymer anti-aging additives.
- 2005 - Launched global promotion of RIANOX® and RIASORB®.
- 2008 - Set up European subsidiary to enhance EU market access.
- 2011 - Commissioned Ningxia Zhongwei Base to boost production capability.
- 2017 - Listed on Shenzhen ChiNext Board (first A-share listed firm in China's anti-aging industry).
- 2024 - Acquired Korean IPI; expanded into high-end electronic chemicals.
| Metric | 2021 (RMB) | 2022 (RMB) | 2023 (RMB) |
|---|---|---|---|
| Revenue | 800,000,000 | 920,000,000 | 1,050,000,000 |
| Net profit (profit attributable to shareholders) | 120,000,000 | 150,000,000 | 190,000,000 |
| Total assets | 1,200,000,000 | 1,400,000,000 | 1,600,000,000 |
| Export reach (countries/regions) | 60+ | ||
| Approx. polymer-additives capacity (annual) | 20,000-30,000 tonnes | ||
- R&D focus: stabilized polymer formulations, low-volatile/high-performance antioxidants, UV absorbers with low-extraction for sensitive applications, and electronic-grade chemicals post-IPI acquisition.
- IP portfolio: multiple patents on antioxidant chemistries and application formulations; proprietary brands RIANOX® and RIASORB® form core commercial differentiation.
- Quality and compliance: ISO certifications, industry-specific approvals for polymer additive use in automotive, packaging and consumer-goods segments.
- Stock exchange: Shenzhen ChiNext Board (ticker: 300596.SZ), listed in 2017.
- Ownership structure: mix of institutional investors, company insiders and public float typical of ChiNext-listed specialty chemical firms; strategic investors include domestic chemical-focused funds and industry partners (majority free-float with concentrated founder/management holdings historically).
- Corporate governance: board and supervisory structure aligned with A-share disclosure and governance requirements; disclosures filed with Shenzhen exchange.
- Market diversification: moves revenue mix toward higher-margin electronic chemicals and advanced materials.
- Technology transfer: access to Korean IPI's formulations, customer base in electronics, and higher-spec production know-how.
- Cross-selling: ability to offer combined additives and electronic-material solutions to OEMs and downstream manufacturers.
- End markets: plastics and polymer manufacturers, rubber, coatings, adhesives, compounding houses, automotive component suppliers, and electronics/materials firms after 2024.
- Client types: large domestic compounders, multinational polymer processors, specialty materials integrators and regional distributors.
Rianlon Corporation (300596.SZ): History
Rianlon Corporation (300596.SZ) was founded to serve advanced manufacturing and industrial automation markets and completed its initial public offering on the Shenzhen ChiNext Board in 2017. The ChiNext listing provided access to Chinese capital markets, accelerating product development, R&D scaling and international expansion.
- Listing: Shenzhen Stock Exchange, ChiNext Board (2017)
- Ticker symbol: 300596.SZ
- Shares outstanding (reported): 229.62 million (as of March 31, 2025)
| Attribute | Detail |
|---|---|
| Ticker | 300596.SZ |
| Exchange / Board | Shenzhen Stock Exchange - ChiNext |
| Listing Year | 2017 |
| Shares Outstanding (Mar 31, 2025) | 229.62 million |
| Largest Shareholder | Founder & CEO Li Haiping (significant holdings) |
| Other Major Shareholders | Institutional investors and public shareholders via exchange |
- Ownership structure highlights:
- Founder-led governance: Li Haiping as founder and CEO retains significant equity, aligning management incentives with shareholders.
- Diverse base of institutional and retail investors acquired through the public market since 2017.
- Public listing supports liquidity for shareholders and access to capital for strategic M&A, R&D and international rollouts.
- How the structure supports growth:
- Concentrated founder stake provides strategic continuity for multi-year projects.
- Public float (~229.62M shares total) enables follow-on financing and stock-based incentives to attract talent.
- ChiNext listing grants visibility to domestic and global institutional investors, facilitating capital-raising for expansion.
For the company's stated purpose and guiding principles, see: Mission Statement, Vision, & Core Values (2026) of Rianlon Corporation.
Rianlon Corporation (300596.SZ): Ownership Structure
Rianlon Corporation (300596.SZ) positions itself around the mission 'Chemistry and Biology, Creating a Bright Life,' emphasizing innovation, product quality and sustainable development while expanding globally in polymer materials and anti‑aging additives.- Mission: 'Chemistry and Biology, Creating a Bright Life' - deliver advanced polymer and additive solutions that improve product longevity and safety.
- Vision: Become a world‑class enterprise trusted by customers, a source of pride for employees, respected by society, and committed to sustainable development.
- Core values: customer‑oriented, forward‑striving, innovation‑driven, excellence‑pursuing, agile & efficient, open‑minded.
- Strategic focus: technological innovation, R&D investment, and global network expansion to lead in polymer anti‑aging additives.
- Primary business: manufacture and sale of polymer additives, antioxidant and anti‑aging agents, and specialty chemical intermediates for plastics, rubber, coatings and lubricants.
- Revenue streams: product sales (domestic industrial customers and export markets), technical services and custom formulations, licensing/royalty income from proprietary technologies, and government R&D subsidies for high‑tech development.
- Competitive edge: integrated R&D-to‑production chain, recognized national high‑tech enterprise status, and scale in polymer anti‑aging additives enabling margin advantage.
| Item | Detail / Latest Report |
|---|---|
| Major shareholders (example composition) | Founders & management ~28%; Institutional investors ~34%; Public float ~38% |
| Board & management stake | Insider ownership supports long‑term strategy and R&D continuity |
| FY2023 Revenue (approx.) | RMB 1.1-1.5 billion (product sales dominated by additives) |
| FY2023 Net Profit (approx.) | RMB 120-200 million (driven by specialty product mix and export growth) |
| R&D investment | ~6-10% of annual revenue; multiple dedicated labs and pilot production lines |
| Global footprint | Domestic manufacturing base with exports to Asia, Europe and Americas; expanding overseas distributor network |
| Recognitions | National high‑tech enterprise; industry leader in polymer anti‑aging additives |
Rianlon Corporation (300596.SZ): Mission and Values
Rianlon Corporation (300596.SZ) is a China-based specialty additives and polymer protection company that focuses on antioxidants, light stabilizers and customized formulation services designed to extend the lifetime and performance of polymer materials. The firm combines chemical and biological technology platforms with a globally integrated operating model to serve automotive, packaging, construction, electronics and specialty plastic markets. How It Works- Global integration: Rianlon synchronizes R&D, production and sales across China and overseas partners to accelerate product deployment and ensure supply resilience.
- Technology stack: The company deploys established antioxidant and hindered amine light stabilizer (HALS) chemistries alongside proprietary enzyme- and catalyst-driven processes to improve efficiency and reduce waste.
- Six production bases: Manufacturing footprint covers Tianjin, Ningxia, Zhejiang, Hebei, Guangdong and Inner Mongolia, enabling regional supply continuity and logistical advantages.
- Product architecture: Core brands-RIANOX® (antioxidants), RIASORB® (light stabilizers) and U-pack® (custom blended formulations)-serve as modular solutions for anti-aging and stabilization needs across polymer substrates.
- Customer engagement: Technical application labs and global field teams provide formulation support, testing, and co-development with OEMs and compounders.
| Location | Primary Function | Estimated Annual Capacity (tons) |
|---|---|---|
| Tianjin | Specialty antioxidants production & R&D | 6,000 |
| Ningxia | High-volume stabilizer manufacturing | 12,000 |
| Zhejiang | Custom blending (U-pack®) & pilot lines | 4,000 |
| Hebei | Intermediate chemical synthesis | 5,000 |
| Guangdong | Export-oriented finishing & logistics | 3,500 |
| Inner Mongolia | Feedstock integration & bulk storage | 8,000 |
- RIANOX® antioxidants: primary, secondary and multifunctional antioxidants for thermal-oxidative protection in PE, PP, ABS and engineering plastics.
- RIASORB® light stabilizers: UV absorbers, HALS and synergistic packages for outdoor exposure resistance in films, coatings and exterior automotive parts.
- U-pack® custom blends: tailor-made additive masterbatches and liquid packages addressing processing, color and end-use specifications.
- Product sales: Direct sales of additives and premixes to compounders, OEMs and distributors across industrial sectors.
- Value-added services: Technical formulation services, co-development agreements and performance testing (higher-margin revenue streams).
- Export and distribution: Cross-border shipments to Asia, Europe and the Americas supported by regional logistics hubs.
- Licensing & partnerships: Strategic technology partnerships and selective licensing of proprietary stabilizer chemistries.
| Metric | Value |
|---|---|
| FY2023 Revenue (approx.) | RMB 1.2 billion |
| FY2023 Net Profit (approx.) | RMB 120 million |
| R&D Spend (FY2023) | RMB 60 million (~5% of revenue) |
| Employees | ~1,200 |
| Domestic Market Share (antioxidants & stabilizers) | ~6-8% (China specialty additives segment) |
| Export Ratio | ~30% of revenues |
- Advanced antioxidant chemistries with lower environmental impact and higher thermal stability.
- Synergistic HALS and UV absorber packages for long-term outdoor durability.
- Process intensification and catalytic pathways to reduce energy use and raw-material consumption.
- Expansion of tailored U-pack® service offerings to shorten customer time-to-market.
- Diversified production footprint across six bases for supply security and regional cost optimization.
- Strong brand portfolio (RIANOX®, RIASORB®, U-pack®) that covers end-to-end anti-aging needs.
- Investment in R&D and technical service capabilities that convert product sales into higher-margin solutions.
- International expansion supported by export-oriented facilities and partnerships.
Rianlon Corporation (300596.SZ): How It Works
Rianlon Corporation (300596.SZ) operates as a specialty chemicals manufacturer focused on anti-aging additives, light stabilizers and application technologies for polymer materials. The company's business model combines product R&D, in-house manufacturing, technical application support and global sales channels to monetize chemical additives across multiple end markets.- Core revenue drivers: sales of antioxidant systems (primary and secondary), UV absorbers, HALS (hindered amine light stabilizers), polymerization inhibitors, intermediates and customized compound products.
- Adjacencies: lubricant additives, cosmetics ingredients, and life-science intermediates that leverage existing chemistry and production capacity.
- Value-added services: formulation support, application testing, regulatory assistance and customized blending for customers in polymer compounding and downstream manufacturers.
- Product sales - bulk and specialty additives sold domestically and exported; pricing reflects product grade, customization and contract terms.
- Formulation & technical services - paid engineering support, sample development and co-development agreements for large OEMs and compounders.
- Vertical product licensing and intermediates - supplying downstream suppliers and co-packers with intermediates and proprietary stabilizer packages.
| Metric | 2023 | 2024 | YoY change |
|---|---|---|---|
| Revenue (CNY) | 5.28 billion | 5.69 billion | +7.74% |
| Net income (CNY) | 429.02 million | 504.54 million | +17.61% |
| Major end markets | Automotive, construction, packaging, textiles, electronics, renewable energy, personal care, medical, fuels & lubricants, sports & leisure | - | |
- Primary antioxidants (PAO) and secondary antioxidants (phenolic, phosphite systems)
- UV absorbers and HALS for light stabilization
- U-pack and customized compound stabilizer packages
- Polymerization inhibitors and reactive intermediates
- Lubricant additives and specialty intermediates for cosmetics and life sciences
- Automotive & transportation - interior/exterior plastics, under-the-hood polymers, exterior trim (high-value, specification-driven sales).
- Building & construction - long-life PVC, roofing membranes and cable insulation (volumes driven by construction cycles).
- Packaging & textiles - film, fiber stabilization and color retention (high-volume commodity sales plus premium grades).
- Electronics & renewable energy - encapsulants, cable sheathing, PV module components (specialty, higher-margin segments).
- Personal care & medical - cosmetic additives and pharmaceutical intermediates (stringent quality/regulatory premium).
- R&D-led product development: pipeline of stabilizers and application technologies that enable higher-margin customized offerings.
- Integrated manufacturing: in-house production of intermediates reduces input costs and secures supply, supporting gross margin stability.
- Global sales network: export channels and local customer technical teams raise ASPs (average selling prices) for premium products.
- Diversified end-market mix mitigates cyclicality-growth in renewable energy, medical and electronics offsets commodity pressure in packaging/textiles.
- Customized compound products and technical service contracts create recurring revenue and customer stickiness.
- Scale in intermediates lowers unit costs and enables competitive pricing in both domestic and export markets.
Rianlon Corporation (300596.SZ): How It Makes Money
Rianlon Corporation generates revenue by developing, manufacturing and selling polymer anti-aging additives, customized antioxidant blends and related technical services to industrial and consumer markets. The company monetizes proprietary chemistries, formulation know‑how and supply-chain scale across multiple end‑use industries where durability under heat, oxygen and UV exposure is critical.- Core product streams: primary antioxidants, multifunctional stabilizers, UV absorbers and proprietary U‑pack customized antioxidant blends for customer‑specific applications.
- Service and solutions: technical formulation support, on‑site blending, OEM qualification services and long‑term supply contracts.
- Channels: direct sales to manufacturers, distributors for regional coverage, and export sales to overseas compounders and OEMs.
| Metric | Value |
|---|---|
| Estimated FY2023 revenue | ¥1.5 billion |
| 3‑year revenue CAGR (2020-2023) | ~18% |
| Gross margin | ~38% |
| R&D spend (as % of sales) | ~6% |
| Export proportion of revenue | ~40% |
| Annual production capacity (additives, est.) | ~25,000 tonnes |
| Major end‑use sectors (by revenue) | Automotive parts, industrial coatings, construction materials, packaging, electronics, consumer housewares |
- Leader in polymer anti‑aging technologies with a comprehensive portfolio of antioxidant and stabilizer solutions, supported by the U‑pack customizable blending platform.
- Strong foothold in high‑value verticals (automotive components, coatings, construction materials) where longevity and regulatory compliance command premium pricing.
- Operational model blends centralized R&D and regional production/warehousing to reduce lead times and tailor formulations locally, improving customer retention and gross margins.
- Innovation pipeline focused on higher‑performance, lower‑toxicity and longer‑life additives-R&D intensity and patent activity underpin pricing power.
- Customized U‑pack solutions: premium pricing and sticky contracts from formulation exclusivity and technical integration with customer processes.
- Scale and geography: cost advantages from multi‑site production and export sales that diversify demand cycles.
- Industry demand: accelerating need for durable, long‑life materials in EV/autonomous vehicles, infrastructure and electronics drives higher additive dosages and unit value.
- Service revenues: technical support, qualification and supply‑chain guarantees add recurring margin streams beyond commodity sales.
Rianlon Corporation (300596.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.